EA201990712A1 - TREATMENT OF MULTIPLE SCLEROSIS BY CHS-131 - Google Patents

TREATMENT OF MULTIPLE SCLEROSIS BY CHS-131

Info

Publication number
EA201990712A1
EA201990712A1 EA201990712A EA201990712A EA201990712A1 EA 201990712 A1 EA201990712 A1 EA 201990712A1 EA 201990712 A EA201990712 A EA 201990712A EA 201990712 A EA201990712 A EA 201990712A EA 201990712 A1 EA201990712 A1 EA 201990712A1
Authority
EA
Eurasian Patent Office
Prior art keywords
chs
multiple sclerosis
treatment
prodrug
women
Prior art date
Application number
EA201990712A
Other languages
Russian (ru)
Inventor
Барбара Финк
Роберт Зивадинов
Хун Тан
Original Assignee
Интекрин Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интекрин Терапьютикс, Инк. filed Critical Интекрин Терапьютикс, Инк.
Priority claimed from PCT/US2017/051414 external-priority patent/WO2018053040A1/en
Publication of EA201990712A1 publication Critical patent/EA201990712A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способы лечения рассеянного склероза (PC) у людей и, в частности, у женщин, включающие введение CHS-131 следующей формулы:или фармацевтически приемлемой соли, пролекарства или изомера CHS-131.Methods of treating multiple sclerosis (PC) in humans and in particular in women, comprising administering CHS-131 of the following formula: or a pharmaceutically acceptable salt, prodrug or isomer of CHS-131.

EA201990712A 2017-04-27 2017-09-13 TREATMENT OF MULTIPLE SCLEROSIS BY CHS-131 EA201990712A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762491071P 2017-04-27 2017-04-27
PCT/US2017/051414 WO2018053040A1 (en) 2016-09-13 2017-09-13 Treatment of multiple sclerosis with chs-131

Publications (1)

Publication Number Publication Date
EA201990712A1 true EA201990712A1 (en) 2019-08-30

Family

ID=67734932

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990712A EA201990712A1 (en) 2017-04-27 2017-09-13 TREATMENT OF MULTIPLE SCLEROSIS BY CHS-131

Country Status (1)

Country Link
EA (1) EA201990712A1 (en)

Similar Documents

Publication Publication Date Title
CY1125089T1 (en) METHODS FOR THE TREATMENT OF CORONAVIRIDAE INFECTIONS
CY1123810T1 (en) TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA
MX2019009443A (en) Methods of treating influenza.
EA201791576A1 (en) JAK INHIBITOR
EA201792116A1 (en) JANUS KINASE INHIBITOR
EA201990951A1 (en) COMBINATIONS CONTAINING SSAO / VAP-1 INHIBITOR AND SGLT2 INHIBITOR, AND THEIR APPLICATION
EA201692436A1 (en) MEDICAL APPLICATION
MX2016015434A (en) Pharmaceutical combinations for treating cancer.
EA201690513A1 (en) COMBINATION OF MEK INHIBITOR AND ERK INHIBITOR FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
MD3416631T2 (en) Therapeutic agents for neurodegenerative diseases
EA201991253A1 (en) BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection
CY1124907T1 (en) KALLIKREIN INHIBITORS IN HUMAN PLASMA
WO2016004413A3 (en) Gls1 inhibitors for treating disease
EA201991688A1 (en) PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF CANCER
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
BR112019004791A2 (en) multiple sclerosis treatment with chs-131
EA202092540A1 (en) COMBINATIONS FOR CANCER TREATMENT
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
EA201792264A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
EA201892098A1 (en) COMPOUND POSSESSING INHIBITING MUTANT IDH ACTIVITY, METHOD FOR PRODUCING AND APPLICATION
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE
PH12021550452A1 (en) Methods of treating mycobacterial infections using tetracycline compounds